125 related articles for article (PubMed ID: 3467840)
1. Potentiation of cytotoxicity of 1-beta-D-arabinofuranosylcytosine for K562 human leukemic cells by cadeguomycin.
Suzuki H; Kim SH; Tanara M; Okazaki K; Okabe T; Wu RT; Tanaka N
Cancer Res; 1987 Feb; 47(3):713-7. PubMed ID: 3467840
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
Grant S; Bhalla K; Rauscher F; Cadman E
Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
[TBL] [Abstract][Full Text] [Related]
3. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells.
Lauzon GJ; Paran JH; Paterson AR
Cancer Res; 1978 Jun; 38(6):1723-9. PubMed ID: 274174
[TBL] [Abstract][Full Text] [Related]
4. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
Plunkett W; Liliemark JO; Adams TM; Nowak B; Estey E; Kantarjian H; Keating MJ
Cancer Res; 1987 Jun; 47(11):3005-11. PubMed ID: 3471322
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
Bhalla K; Nayak R; Grant S
Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
[TBL] [Abstract][Full Text] [Related]
6. Role of uridine triphosphate in the phosphorylation of 1-beta-D-arabinofuranosylcytosine by Ehrlich ascites tumor cells.
White JC; Hines LH
Cancer Res; 1987 Apr; 47(7):1820-4. PubMed ID: 3028615
[TBL] [Abstract][Full Text] [Related]
7. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
Vilpo JA; Vilpo LM
Cancer Res; 1988 Jun; 48(11):3117-22. PubMed ID: 3163271
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of synergistic cell killing by hydroxyurea and cytosine arabinoside.
Tanaka M; Kimura K; Yoshida S
Jpn J Cancer Res; 1985 Aug; 76(8):729-35. PubMed ID: 3930450
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
Chandrasekaran B; Capizzi RL; Kute TE; Morgan T; Dimling J
Cancer Res; 1989 Jun; 49(12):3259-66. PubMed ID: 2720678
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosine.
Grem JL; Allegra CJ
Cancer Res; 1990 Nov; 50(22):7279-84. PubMed ID: 1699659
[TBL] [Abstract][Full Text] [Related]
11. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
Vadi H; Drewinko B
Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
Nandy P; Lien EJ; Avramis VI
Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
[TBL] [Abstract][Full Text] [Related]
13. Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism.
Karp JE; Donehower RC; Dole GB; Burke PJ
Cancer Res; 1984 Nov; 44(11):5046-50. PubMed ID: 6488163
[TBL] [Abstract][Full Text] [Related]
14. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate.
Liliemark JO; Plunkett W
Cancer Res; 1986 Mar; 46(3):1079-83. PubMed ID: 3484676
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cell-killing effects of 1-beta-D-arabinofuranosylcytosine and daunorubicin by a new computer-controlled in vitro pharmacokinetic simulation system.
Kishi S; Goto N; Nakamura T; Ueda T
Cancer Res; 1999 Jun; 59(11):2629-34. PubMed ID: 10363985
[TBL] [Abstract][Full Text] [Related]
16. Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosine.
Ross DD; Akman SA; Joneckis CC; Yang E; Bachur NR
Cancer Res; 1984 Apr; 44(4):1530-5. PubMed ID: 6584206
[TBL] [Abstract][Full Text] [Related]
17. A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-beta-D-arabinofuranosylcytosine phosphorylation in human leukemia cells.
White JC; Capizzi RL
Cancer Res; 1991 May; 51(10):2559-65. PubMed ID: 2021937
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
Grant S; Turner A; Nelms P; Yanovich S
Leukemia; 1995 May; 9(5):808-14. PubMed ID: 7769843
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA
Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
[TBL] [Abstract][Full Text] [Related]
20. Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells.
Gandhi V; Plunkett W
Cancer Res; 1988 Jan; 48(2):329-34. PubMed ID: 3335008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
